Global /Taiwan /Healthcare /Drug Manufacturers - Specialty & Generic /4127

Tien Liang BioTech Co., Ltd.

4127

• TPEX: 4127 • Delayed

38.35TWD 1.9%

1.22 USD

As of 6 June 2026, Tien Liang BioTech Co., Ltd. has a market cap of $54.77M USD, ranking #29950 globally and #1788 in Taiwan. It ranks #2714 in the Healthcare sector, and #155 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

29950

Country Rank

1788

Sector Rank

2714

Industry Rank

155

Key Stats

Market Cap

$54.77MUSD

1.72B TWD

Enterprise Value

$68.94MUSD

2.17B TWD

Revenue (TTM)

$16.27MUSD

511.79M TWD

EBITDA (TTM)

-$209.05KUSD

-6.58M TWD

Net Income (TTM)

-$325.88KUSD

-10.25M TWD

EBITDA Margin

-1.3%

Profit Margin

-2%

PS Ratio

3.4

PB Ratio

3.6

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Min-Chung Chi open_in_new

Employees

Founded

1971

Website

tlb.com.tw open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.9%	2.3%	7.9%	-6%	21%	24%	5.6%	144%	264%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	4127 天良生物科技企業股份有限公司 ISIN: TW0004127006 Shares Out.: Shares Outstanding: 45.76M¹ Shares Float: 33.658M² TV: TradingView: TPEX: 4127 SA: Stock Analysis: TPEX: 4127 YF: Yahoo Finance: 4127.TWO GF: Google Finance: TPEX: 4127 BA: Barron's: 4127 MS: Morningstar: ROCO: 4127	38.35 TWD	TV: TradingView: TPEX: 4127 SA: Stock Analysis: TPEX: 4127 YF: Yahoo Finance: 4127.TWO GF: Google Finance: TPEX: 4127 BA: Barron's: 4127 MS: Morningstar: ROCO: 4127

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Tien Liang BioTech Co., Ltd.

Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan. The company offers Chinese and Western medicine, other healthcare, and cosmetic products through online and offline channels. Tien Liang BioTech Co., Ltd. was founded in 1971 and is based in New Taipei City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
Bora Pharmaceuticals Co., Ltd. TWSE: 6472	$1.68B 52.95B TWD 3K%	17.9	Taiwan
Grape King Bio Ltd. TWSE: 1707	$536.85M 16.89B TWD 880%	14.0	Taiwan
Daiken Biomedical Co., Ltd. TWSE: 7780	$476.38M 14.99B TWD 770%	36.5	Taiwan
TCI Co., Ltd. TPEX: 8436	$415.07M 13.06B TWD 658%	13.7	Taiwan
Microbio Co., Ltd. TPEX: 4128	$291.68M 9.18B TWD 433%	-	Taiwan
Intelligene Inc. TPEX: 7832	$244.3M 7.69B TWD 346%	-	Taiwan

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 69K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 54K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 29K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 20K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 20K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 17K%	80.6	China

chevron_leftBack